These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. p38δ genetic ablation protects female mice from anthracycline cardiotoxicity. George SA; Kiss A; Obaid SN; Venegas A; Talapatra T; Wei C; Efimova T; Efimov IR Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H775-H786. PubMed ID: 32822209 [TBL] [Abstract][Full Text] [Related]
4. Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension. Tam AYY; Horwell AL; Trinder SL; Khan K; Xu S; Ong V; Denton CP; Norman JT; Holmes AM; Bou-Gharios G; Abraham DJ Int J Biochem Cell Biol; 2021 May; 134():105961. PubMed ID: 33662577 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of Kininogen-1 aggravates oxidative stress and mitochondrial dysfunction in DOX-induced cardiotoxicity. Cheng X; Liu D; Song H; Tian X; Yan C; Han Y Biochem Biophys Res Commun; 2021 Apr; 550():142-150. PubMed ID: 33706097 [TBL] [Abstract][Full Text] [Related]
6. Senescence marker protein 30 has a cardio-protective role in doxorubicin-induced cardiac dysfunction. Miyata M; Suzuki S; Misaka T; Shishido T; Saitoh S; Ishigami A; Kubota I; Takeishi Y PLoS One; 2013; 8(12):e79093. PubMed ID: 24391705 [TBL] [Abstract][Full Text] [Related]
7. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress. Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254 [TBL] [Abstract][Full Text] [Related]
8. 8-Formylophiopogonanone B antagonizes doxorubicin-induced cardiotoxicity by suppressing heme oxygenase-1-dependent myocardial inflammation and fibrosis. Qin D; Yue R; Deng P; Wang X; Zheng Z; Lv M; Zhang Y; Pu J; Xu J; Liang Y; Pi H; Yu Z; Hu H Biomed Pharmacother; 2021 Aug; 140():111779. PubMed ID: 34062415 [TBL] [Abstract][Full Text] [Related]
9. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction. Li S; Wang W; Niu T; Wang H; Li B; Shao L; Lai Y; Li H; Janicki JS; Wang XL; Tang D; Cui T Oxid Med Cell Longev; 2014; 2014():748524. PubMed ID: 24895528 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of TRIM16 mitigates doxorubicin-induced cardiotoxicity by modulating TAK1 and YAP/Nrf2 pathways in mice. Guo X; Liu M; Han B; Zheng Y; Zhang K; Bao G; Gao C; Shi H; Sun Q; Zhao Z Biochem Pharmacol; 2024 Feb; 220():116009. PubMed ID: 38154547 [TBL] [Abstract][Full Text] [Related]
11. Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice. Zhang W; Deng J; Sunkara M; Morris AJ; Wang C; St Clair D; Vore M J Pharmacol Exp Ther; 2015 Nov; 355(2):280-7. PubMed ID: 26354995 [TBL] [Abstract][Full Text] [Related]
12. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling. Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice. Ye J; Huang Y; Que B; Chang C; Liu W; Hu H; Liu L; Shi Y; Wang Y; Wang M; Zeng T; Zhen W; Xu Y; Shi L; Liu J; Jiang H; Ye D; Lin Y; Wan J; Ji Q EBioMedicine; 2018 Sep; 35():29-39. PubMed ID: 30228093 [TBL] [Abstract][Full Text] [Related]
15. Protective effects of dimethyl itaconate in mice acute cardiotoxicity induced by doxorubicin. Shan Q; Li X; Zheng M; Lin X; Lu G; Su D; Lu X Biochem Biophys Res Commun; 2019 Sep; 517(3):538-544. PubMed ID: 31376936 [TBL] [Abstract][Full Text] [Related]
16. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2/Sirt3 signaling pathway. Gu J; Huang H; Liu C; Jiang B; Li M; Liu L; Zhang S Int Immunopharmacol; 2021 Jun; 95():107533. PubMed ID: 33752080 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2. Zhao L; Qi Y; Xu L; Tao X; Han X; Yin L; Peng J Redox Biol; 2018 May; 15():284-296. PubMed ID: 29304479 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress. Zhao L; Tao X; Qi Y; Xu L; Yin L; Peng J Redox Biol; 2018 Jun; 16():189-198. PubMed ID: 29524841 [TBL] [Abstract][Full Text] [Related]
19. GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress. Wang Y; Lei T; Yuan J; Wu Y; Shen X; Gao J; Feng W; Lu Z Redox Biol; 2018 Jul; 17():25-34. PubMed ID: 29660505 [TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice. Ma ZG; Kong CY; Wu HM; Song P; Zhang X; Yuan YP; Deng W; Tang QZ Theranostics; 2020; 10(24):11013-11025. PubMed ID: 33042267 [No Abstract] [Full Text] [Related] [Next] [New Search]